Hotline For COVID-19 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
COVID-19 Vaccine Hotline 1214
Are you a new member? Sign up now
 
close

UPTRAVI - 200mcg - 140

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date
B01AC27 B Selexipag - 200mcg 9249 88517/1 UPTRAVI 200mcg 140 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 10,939,198 L.L 2.44 E2 Actelion Pharmaceuticals Ltd Switzerland 03/01/2022

Drugs With Same Ingredients

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date
B01AC27 B Selexipag - 200mcg 9250 88617/1 UPTRAVI 200mcg 60 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 5,231,976 L.L 2.44 E2 Actelion Pharmaceuticals Ltd Switzerland 03/01/2022
B01AC27 B Selexipag - 200mcg 10408 14620/1 UPTRAVI 200mcg 60 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 5,231,976 L.L 2.44 E2 Janssen Cilag International NV Belgium 03/01/2022
B01AC27 B Selexipag - 200mcg 10409 14720/1 UPTRAVI 200mcg 140 Tablet, film coated Oral Mersaco Excella GmbH & Co KG Germany 10,939,198 L.L 2.44 E2 Janssen Cilag International NV Belgium 03/01/2022
Sitemap
© Copyrights reserved to Ministry of Public Health 2022